Top 10 Companies in the Pancreatin Market (2026): Key Players Shaping Digestive Health Solutions

In Business Insights
January 23, 2026


The Global Pancreatin Market was valued at US$ 104 Million in 2025 and is projected to reach US$ 160 Million by 2034, growing at a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period (2024–2034). This steady growth is propelled by the rising global prevalence of pancreatic exocrine insufficiency (PEI), increasing diagnosis of digestive disorders, and the expanding application of digestive enzymes in pharmaceuticals, food processing, and animal nutrition.

As demand for effective enzyme therapies surges, the market is being driven by key manufacturers who ensure stringent quality control, supply chain reliability, and continuous innovation in enzyme formulations. In this analysis, we examine the Top 10 Companies in the Pancreatin Industry—a group of established pharmaceutical ingredient suppliers, specialized enzyme producers, and emerging bio-pharma players critical to global digestive health.


🔟 1. Nordmark

Headquarters: Uetersen, Germany
Key Offering: High-Purity Porcine Pancreatin, Pharmaceutical-Grade Enzymes

Nordmark is a globally recognized leader in the production of high-quality pancreatin derived from porcine pancreas. With decades of specialized expertise, the company supplies pharmacopeia-grade enzymes to the global pharmaceutical industry, adhering to strict Good Manufacturing Practice (GMP) standards. Nordmark’s products are essential for treating conditions like cystic fibrosis and chronic pancreatitis.

Innovation and Quality Focus:

  • Specialization in enzyme activity standardization and stability

  • Rigorous quality control from raw material sourcing to final product

  • Continuous process optimization for consistent enzyme potency

Download FREE Sample Report:
Pancreatin Market – View in Detailed Research Report


9️⃣ 2. Sichuan Deebio

Headquarters: Chengdu, Sichuan, China
Key Offering: Porcine & Bovine Pancreatin, Food and Pharma Grades

Sichuan Deebio is a major Chinese manufacturer of pancreatin and other biochemical products, serving both domestic and international markets. The company has established a strong position in the Asia-Pacific region, leveraging China’s significant pharmaceutical and food processing industries. Deebio’s product portfolio includes various enzyme activity specifications tailored to different industrial applications.

Market Position and Expansion:

  • Significant market share in the rapidly growing Asian pancreatin market

  • Investment in production capacity expansion to meet rising global demand


8️⃣ 3. Shenzhen Hepalink

Headquarters: Shenzhen, Guangdong, China
Key Offering: Heparin Sodium, Porcine Pancreatin, API Ingredients

Shenzhen Hepalink is a leading global supplier of pharmaceutical ingredients, with pancreatin being one of its key biochemical products. The company benefits from vertical integration and extensive experience in processing animal-derived APIs. Hepalink’s established global distribution network ensures reliable supply to pharmaceutical customers worldwide.

Strategic Advantages:

  • Vertical integration in animal-sourced pharmaceutical ingredients

  • Strong R&D capabilities in purification and standardization techniques


7️⃣ 4. Terhormon

Headquarters: Budapest, Hungary
Key Offering: European-Sourced Porcine Pancreatin, Custom Formulations

Terhormon is a European specialist in pancreatin production, focusing on high-quality enzymes sourced from regulated European suppliers. The company serves pharmaceutical manufacturers requiring consistent quality and reliable supply. Terhormon’s expertise includes developing customized enzyme formulations for specific therapeutic applications.

Quality and Customization Focus:

  • Emphasis on traceability and quality assurance of raw materials

  • Custom formulation capabilities for specialized pharmaceutical applications


6️⃣ 5. American Laboratories (ALI)

Headquarters: Omaha, Nebraska, USA
Key Offering: USP-Grade Pancreatin, Animal Protein Hydrolysates

American Laboratories has been a prominent North American supplier of animal-derived enzymes and protein ingredients for over 40 years. The company produces United States Pharmacopeia (USP)-grade pancreatin, serving pharmaceutical companies and diagnostic manufacturers. ALI’s stringent quality systems ensure compliance with FDA regulations and customer specifications.

Regulatory and Quality Compliance:

  • Strict adherence to USP monographs and FDA regulatory requirements

  • Established reputation for consistency and reliability in the North American market

Download FREE Sample Report:
Pancreatin Market – View in Detailed Research Report


5️⃣ 6. Changzhou Qianhong Biopharma

Headquarters: Changzhou, Jiangsu, China
Key Offering: Biopharmaceutical Enzymes, Heparin, Pancreatin APIs

Changzhou Qianhong Biopharma is a Chinese pharmaceutical company with a diverse portfolio of enzyme products, including pharmaceutical-grade pancreatin. The company has invested in modern production facilities and R&D capabilities to serve the growing domestic and international markets for digestive enzyme preparations.

Growth Strategy:

  • Expansion of production capacity for pharmaceutical enzymes

  • Focus on quality upgrades to meet international regulatory standards


4️⃣ 7. Sichuan Biosyn

Headquarters: Chengdu, Sichuan, China
Key Offering: Specialty Enzymes, Biochemical Extracts

Sichuan Biosyn specializes in the extraction and purification of biological enzymes, with pancreatin being a key product in their portfolio. The company serves pharmaceutical, food, and industrial customers with tailored enzyme solutions. Sichuan Biosyn leverages China’s robust biological resources and manufacturing capabilities.

Market Approach:

  • Focus on cost-effective production while maintaining quality standards

  • Growing export business to emerging markets


3️⃣ 8. Chongqing Aoli

Headquarters: Chongqing, China
Key Offering: Pancreatin Powder, Enzyme Preparations

Chongqing Aoli is part of China’s growing biopharmaceutical sector, producing pancreatin and other enzyme products primarily for the domestic market. The company benefits from Chongqing’s established pharmaceutical industry and access to raw materials from China’s significant pork production industry.

Regional Strengths:

  • Strategic location in a major Chinese pharmaceutical manufacturing hub

  • Cost-competitive production for price-sensitive market segments


2️⃣ 9. Chongqing Quanxin Xiangsheng

Headquarters: Chongqing, China
Key Offering: Animal-Derived Enzymes, Biochemical Products

Chongqing Quanxin Xiangsheng is another significant Chinese player in the pancreatin market, focusing on enzyme extraction from animal tissues. The company supplies both domestic pharmaceutical manufacturers and international customers seeking cost-effective enzyme ingredients.

Production Capabilities:

  • Modern extraction and purification facilities

  • Scalable production to accommodate fluctuating market demand


1️⃣ 10. Geyuan Tianrun

Headquarters: Gansu, China
Key Offering: Pharmaceutical Intermediates, Enzyme Products

Geyuan Tianrun specializes in pharmaceutical intermediates and biological products, including pancreatin for medicinal use. The company serves the growing Chinese pharmaceutical market and exports to select international markets. Geyuan Tianrun focuses on maintaining competitive positioning through efficient production processes.

Market Positioning:

  • Focus on serving the rapidly expanding Chinese healthcare market

  • Continuous improvement in production efficiency and cost management

Get Full Report Here:
Pancreatin Market – View in Detailed Research Report


🌍 Outlook: The Future of Pancreatin Markets and Innovation

The pancreatin market is experiencing steady evolution, driven by demographic trends, healthcare advancements, and technological improvements in enzyme production. While traditional porcine-sourced pancreatin continues to dominate, the industry is exploring new frontiers in enzyme therapy and alternative sourcing.

📈 Key Trends Shaping the Market:

  • Increasing global prevalence of pancreatic diseases and digestive disorders requiring enzyme replacement therapy

  • Growing adoption of pancreatin in animal feed to improve nutrient absorption and growth efficiency

  • Advancements in enzyme stabilization and delivery technologies for improved therapeutic efficacy

  • Stringent regulatory requirements driving quality improvements and standardization across the industry

Get Full Report Here:
Pancreatin Market – View in Detailed Research Report

The companies profiled above represent the foundation of global pancreatin supply—ensuring that patients worldwide have access to essential digestive enzyme therapies while supporting advancements in nutritional science and animal health.